-
1 Comment
Medical Data Vision Co., Ltd is currently in a long term downtrend where the price is trading 15.0% below its 200 day moving average.
From a valuation standpoint, the stock is 74.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.1.
Medical Data Vision Co., Ltd's total revenue rose by 12.4% to $1B since the same quarter in the previous year.
Its net income has dropped by 28.5% to $173M since the same quarter in the previous year.
Based on the above factors, Medical Data Vision Co., Ltd gets an overall score of 2/5.
| ISIN | JP3921250001 |
|---|---|
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Health Information Services |
| Target Price | 430 |
|---|---|
| Dividend Yield | 3.6% |
| Beta | 1.0 |
| Market Cap | 16B |
| PE Ratio | None |
Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company offers data network services; data utilization services; MDV act, an analysis application that enables hospitals to preview hospital management indicators; and Karteco, a personal health record enables users to independently manage their health and medical information. It also provides research, and consulting services for various medical data; business consulting services for medical institutions; and operation and related service of various medical data. In addition, it engages in the planning, design, development, and operation of portal websites. The company serves hospitals, clinics, and companies. Medical Data Vision Co., Ltd. was incorporated in 2003 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3902.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
